Iseikai Hospital

Name

Iseikai Hospital

Legal name

Medical Corporation Iseikai (、医療法人医誠会)

Website

https://iseikaihp.or.jp

Company type

Private

Founded year

1983

Operating status

Operating

Ownership category

akta.pro rank

Headquarters

HQ city

Osaka

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Pricing tiers

Distribution channels4 records

Marketing channels8 records

Core offering

Iseikai Hospital is a regional comprehensive general hospital (medical corporation) providing acute, emergency, inpatient, and outpatient care across multiple specialties. It operates specialized centers in cardiovascular medicine, oncology, genomic/personalized medicine, regenerative medicine, intractable/rare diseases, and dementia prevention, supported by robotic surgery, an on-site next-generation genome sequencer, and a 24/7 inter-facility emergency transport system serving 20 municipalities in the Osaka metropolitan area.

Product overview

Iseikai Hospital is a comprehensive medical institution offering a diverse portfolio of specialized medical services centered around its core hospital facilities. The hospital operates multiple dedicated centers including the Outpatient Chemotherapy Center, Cardiovascular Center, Intractable Disease Center, Dementia Prevention and Treatment Center, and Regenerative Medicine Center. The hospital provides advanced genomic medicine services through its Genome Medicine program, which encompasses cancer genome testing, APOE gene testing, pharmacogenomics, and genetic counseling across multiple specialties. Surgical services include robotic surgery with certified surgeons. The hospital also offers specialized diagnostic services such as the MySignal urine cancer test and Human Dock SOPHIA health examination program. Supporting infrastructure includes a 24-hour emergency transport system, medical simulation training, and an AI Hospital initiative for digital healthcare transformation.

Differentiator

Problem solved

Functional benefit

Brands

• i-Mall (アイモール): Medical complex facility integrating hospital services with other healthcare and wellness services
• Hospital Kyukyu Transport System (病院救急)
• SAKURA Volunteer Program (医誠会ボランティアSAKURA)
• Sakura Childcare (さくら保育園/病児・病後児保育園)

Products and services

• Outpatient Chemotherapy Center (外来化学療法センター) Outpatient chemotherapy center providing cancer treatment while patients maintain daily life, with 20 reclining chairs, 7 beds including private rooms, and privacy partitions for each treatment space.
• Genome Medicine Program (ゲノム医療) Comprehensive genomic medicine program including cancer genome testing (50 genes), APOE gene testing for Alzheimer's risk, pharmacogenomics, and genetic counseling across pediatrics, neurology, cardiovascular medicine, nephrology, and otolaryngology.
• Cardiovascular Center (心臓血管センター) Comprehensive cardiovascular center integrating cardiovascular medicine, cardiovascular surgery, and peripheral vascular surgery with specialization in valvular disease diagnosis and catheter-based and surgical interventions.
• Regenerative Medicine Center (再生医療センター) Regenerative medicine center offering cutting-edge treatments and anti-aging strategies as part of the hospital's advanced treatment initiatives.
• Intractable Disease Center (難病医療推進センター) Center dedicated to promoting treatment for rare and intractable diseases, with genome analysis capabilities and seminars on latest treatment approaches.
• Dementia Prevention and Treatment Center (認知症予防治療センター) Specialized center for Alzheimer's disease treatment using disease-modifying drugs (including Lecanemab), advanced imaging (PET, MRI, SPECT), blood biomarkers, and evidence-based exercise therapy and nutritional guidance.
• Robotic Surgery (ロボティックサージャリー) Robotic-assisted surgery program with certified console surgeons, offering minimally invasive surgical options including robotic cardiac surgery.
• Urine Cancer Test MySignal (尿がん検査マイシグナル) Non-invasive urine-based cancer screening test that can assess cancer risk for 10 types of cancer in both men and women with a single urine sample.
• Human Dock SOPHIA (人間ドックSOPHIA) Premium health examination service including cancer genome dock and comprehensive genomic diagnostics, offering cancer genome testing as part of health screening.
• Emergency Transport System (病院救急搬送システム) 24-hour/365-day hospital emergency vehicle transport system with 30 paramedics providing free facility-to-facility transport within a 10km radius, including patient pickup from nearby hospitals and care facilities.
• Private Hospital Service (プライベートホスピタルサービス) Concierge service offering premium hospital experience with personalized care and attention.
• Postpartum Care and Painless Delivery (卒後ケア・無痛分娩) Comprehensive maternity services including painless delivery options and postpartum care programs for mothers and newborns.
• Simulation Medicine (シミュレーションメディカル) Medical simulation training programs including BLS, ICLS, NCPR, RRS, fire evacuation drills, disaster response training, and BCP exercises for clinical staff.
• AI Hospital / Medical DX (AI病院 医療DX) AI-enabled hospital digital transformation initiative implementing online qualification verification, My Number insurance card promotion, electronic prescription issuance, and electronic medical record information sharing services.
• Genome Pharmacology Testing (ゲノム薬理学検査) Pharmacogenomic testing service enabling drug efficacy and allergy susceptibility testing based on individual genetic profiles, available as part of Human Dock SOPHIA premium screening.

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core and secondary.

• Osaka International Cancer Center (大阪国際がんセンター)coreStrategic or Co-development PartnerIseikai International General Hospital is a registered collaborating medical institution of the Osaka International Cancer Center, enabling coordinated cancer care, referrals, and shared treatment protocols for cancer patients requiring specialized or advanced treatment beyond the hospital's capabilities.
• Ezaki Glico Co., Ltd. (江崎グリコ株式会社)secondaryGTM or Marketing PartnerJoint pediatric health seminars co-organized with Ezaki Glico targeting pregnant women and parents of young children. Multiple seminar sessions have been held at the hospital, covering topics on child health, nutrition, and development. This partnership provides community outreach and patient acquisition through Glico's consumer brand reach.
• Aino University (藍野大学)secondaryStrategic or Co-development PartnerComprehensive cooperation agreement signed between Iseikai Medical Corporation and Aino University, enabling collaborative education, clinical training, and research initiatives between the hospital and university.
• NPO Future Process (株式会社未来プロセス)secondaryGTM or Marketing PartnerCollaborative organization that co-hosts the Holonics Public Medical Lecture Series (ホロニクス公開医学講座), Health Forum, and community health events at the hospital. NPO Future Process provides health awareness education and organizes public lectures with hospital medical staff as speakers, serving as a community outreach and health literacy partnership.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Kameda Medical Center: Large private general hospital in Chiba with comprehensive specialty centers, JCI accreditation, and strong international patient program. Comparable in scale, service breadth, and premium private positioning in Japan.
• St. Luke's International Hospital: Tokyo-based JCI-accredited general hospital with similar international patient services, advanced specialty centers, and reputation for high-end care in Japan. Directly comparable in scope, quality positioning, and private medical corporation structure.
• Sanno Hospital: Tokyo-based premium private hospital with JCI accreditation, advanced specialty centers, and concierge-style private hospital services — directly comparable to Iseikai's Private Hospital Service offering and international patient positioning.
• Mitsui Memorial Hospital: Tokyo-based private general hospital with comprehensive specialty services, advanced diagnostics, and premium positioning. Comparable in scale, private medical corporation structure, and urban tertiary care focus.

Emerging players

• Kyoto University Hospital: Major Kansai-region academic medical center with strong genomic medicine, iPS cell-based regenerative medicine, and specialty programs. Geographic peer in the Kansai region with overlapping advanced therapy capabilities.
• Keio University Hospital: Tokyo academic medical center with leading genomic medicine and personalized cancer treatment programs. Relevant peer for Iseikai's genome medicine and cancer genome testing capabilities, particularly as competition for high-acuity referrals.

Broad incumbents

• Tokushukai Medical Group: One of Japan's largest private hospital networks (over 70 facilities) with comprehensive services including emergency transport, oncology, and cardiovascular care. Operates at greater scale than Iseikai with similar multi-specialty positioning.
• Seikeikai Group (Saiseikai): Large nationwide network of general hospitals across Japan with emergency services, oncology, and comprehensive specialty care. Comparable in general hospital service breadth, though operates as a social welfare organization rather than private corporation.
• National Cancer Center Japan: Japan's premier cancer treatment institution, headquartered in Tokyo with affiliated centers. Iseikai is a registered collaborator with the Osaka branch, indicating direct peer relationship in oncology service lines.
• Osaka University Hospital: Major academic medical center in Osaka with leading genomic medicine, cancer treatment, and specialty programs. Overlaps with Iseikai's Osaka market, genome medicine, and oncology services but operates at significantly larger scale with academic research capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/iseikai3
• YouTubeyoutube.com/channel/UCiEga6_83N_8MxsZYm3Kj9A/videos
• Instagraminstagram.com/iseikai

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Iseikai Hospital